Peter Harwin
Board Member
Crescent Biopharma, Inc. (CBIO)Chairman
Crescent Biopharma, Inc. (CBIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter Harwin
Peter Harwin is recorded as Board Member and Chairman at Crescent Biopharma, Inc. (CBIO). Crescent Biopharma, Inc. reported in an 8-K filed June 18, 2025 that Peter Harwin was appointed Chair of the Board, effective June 13, 2025. Crescent Biopharma, Inc. reported in an 8-K filed June 18, 2025 that Peter Harwin was appointed director, effective June 13, 2025.
“In connection with his appointment to the Board, Peter Harwin was also appointed as Chair of the Board.”
“On June 13, 2025, the Board decreased its size from eight to six members and appointed the following six individuals to the Board: Peter Harwin, Alexandra Balcom, Joshua Brumm, David Lubner, Susan Moran and Jonathan Violin.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-13–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Crescent Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Joshua Brumm CEO, Board Member
- Richard Scalzo CFO
- Rick Scalzo CFO
- Jonathan McNeill COO
- Barbara Bispham General Counsel
- Barbara Bispham Hale General Counsel
- Ryan Lynch Chief Accounting Officer
- Alexandra Balcom Board Member
- David Lubner Board Member
- Jonathan Violin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.